-
-
-
-
-
-
-
Transition Bio and Voyager partner on TDP-43 drugs for ALS and dementia
-
-
-
-
-
-
-
Voyager Therapeutics (VYGR) Presents Robust Preclinical Data from Tau Targeting Gene Therapy
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Voyager Therapeutics (VYGR)
-
-
-
-
-
-
-
Voyager Therapeutics (VYGR) Advances Collaboration with Neurocrine
-
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

